Insmed
INSM104.7050.02% ( -0.025 )
Insmed (INSM)
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally....
- Open
- 104.730
- High
- 105.760
- Low
- 103.180
- Prev. Close
- 104.730
- Volume
- 1.01M
- Turnover
- 105.82M
- Avg Price
- 104.680
- Bid/Ask Ratio
- --
- Amplitude
- 2.46%
- 52wk High
- 212.750
- Volume Ratio
- 0.61
- Turnover Ratio
- 0.51%
Insmed Analyst Rating
View MoreForecast & Rating
Jul 28, 2026Price forecast
$196.1887.78%
Forecast & RatingStrong buy
23analysts
- Strong buy78.26%
- Buy21.74%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 9 hours ago
Global Repositioning: PayPal's Buyout Rejection and Otis's Valuation Reset
- PUBT · Jul 24 at 04:03 PM
Insmed Chair and CEO William Lewis disposes of 10,700 common shares worth $1.14 million
- PUBT · Jul 23 at 06:01 AM
Insmed to release Q2 2026 results, host investor conference call
- benzinga_article · Jul 21 at 06:58 AM
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
- Market Beat · Jul 21 at 02:29 AM
Fifth Third Bancorp Boosts Stock Position in Insmed, Inc. $INSM
- Tip Ranks · Jul 16 at 12:15 PM
Matt Phipps Reiterates Buy on Insmed, Citing Strong TPIP PAH Data, Solid Brinsupri/Arikayce Growth, and Overdone Share Pullback
